Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
When planning a moderately hypofractionationed treatment for prostate cancer, do you recommend using a bladder volume dose constraint?
For example V70<10cc? Or do you stick with % of organ volume dose constraints?
Answer from: Radiation Oncologist at Community Practice
We aim for 70 Gy < 10 and 35 Gy < 40 - 50 and try to avoid hot spot in bladder trigone region.
Comments
Radiation Oncologist at CCare
I noticed 70Gy <10cc and the lower V40 constrai...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
We do treat all with hypofractionation.
6198
6199
Sign in or Register to read more
10419
Related Questions
Would you consider re-irradiation in the setting of prior salvage prostatectomy after prostate brachytherapy?
If a patient diagnosed with seminoma after orchiectomy has margin positive disease noted in the spermatic cord and no overt metastasis on imaging and normal tumor markers, how should this patient be staged?
For patients with metastatic RCC and gross hematuria from the primary tumor, what palliative radiation regimen would you recommend to help control the bleeding?
How would you treat a patient with retroperitoneal lymphadenopathy that has been biopsy proven metastatic seminoma, who is not a candidate for orchiectomy, RPLND, or systemic therapy?
Are patients with MIBC and bladder neck involvement good candidates for bladder preservation with chemoradiation after maximal, but not complete, TURBT?
What duration androgen deprivation do you recommend with salvage pelvic radiotherapy for pelvic node relapse after prostatectomy?
How do you manage significant gas in patients undergoing pelvic radiotherapy?
How do you approach Lu-177 use in taxane-naive patients with metastatic prostate cancer?
Would you offer palliative radiation to a patient with hematuria from squamous metaplasia of the bladder that is not responding to endoscopic therapy?
Given results of BCON trial, do you add carbogen and nicotinamide for patients receiving definitive radiotherapy for bladder cancer, particularly for non-cisplatin eligible candidates?
I noticed 70Gy <10cc and the lower V40 constrai...
We do treat all with hypofractionation.